Research News for September 2011
11–20 of 20 articles
-
“Personality” of Cancer Affects Recurrence Risk After Lumpectomy, Not When Chemo is Given
A study has found that cancer characteristics, not the timing of chemotherapy, affect the risk of recurrence in women diagnosed with early-stage breast cancer who had lumpectomy.
-
Women with Disease Linked to Abnormal Breast Cancer Gene Are Younger When Diagnosed Compared to Previous Generation
Research suggests that women diagnosed with breast or ovarian cancer linked to an inherited abnormal breast cancer are younger when diagnosed compared to their older relatives.
-
Internal Mammary Lymph Node Radiation Doesn’t Lower Recurrence Risk
Research suggests that internal mammary node radiation for women diagnosed with early-stage breast cancer that is large and/or has spread to the lymph nodes doesn't reduce recurrence risk or improve survival.
-
No Difference in Prognosis with Sentinel Node Biopsy Versus Axillary Node Biopsy
Research shows that women who had sentinel node biopsy did just as well as women who had axillary node biopsy, even though small clusters of breast cancer cells may have been in the axillary lymph nodes of the women who had sentinel node biopsy.
-
Study Supports Mammograms and Breast Self-Exams Starting at 40
A large study offers more evidence that annual mammograms benefit all women, including women 40 to 50 years old.
-
Tykerb Alone Doesn’t Work as Well as Herceptin Alone to Treat Early-Stage, HER2-Positive Disease
Early results from the ALTTO study show that Tykerb doesn't work as well as Herceptin when given alone after surgery to treat early-stage, HER2-positive breast cancer.
-
Online Tool May Help Predict Lymphedema Risk
A new online tool does a good job of predicting the risk of lymphedema after breast cancer surgery.
-
Lumpectomy and Radiation Therapy as Good as Mastectomy for Younger Women
Research shows that young women who had lumpectomy followed by radiation therapy were no more likely to have the breast cancer come back and just as likely to survive breast cancer as young women who had mastectomy.
-
Most Women with Early-Stage Breast Cancer Benefit from Treatments After Surgery
Research suggests that that most women diagnosed with early-stage breast cancer are likely to benefit from chemotherapy, hormonal therapy, and/or targeted therapy after surgery.
-
FDA Warning: Reclast May Cause Severe Kidney Problems
On Sept. 1, 2011 the U.S. Food and Drug Administration warned doctors and patients that Reclast may cause severe kidney problems.
11–20 of 20 articles
